Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
$4.80
+31.9%
$3.89
$2.34
$8.79
$173.10MN/A206,521 shs367,914 shs
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$1.52
-4.4%
$1.35
$0.68
$1.80
$164.45M1.28532,857 shs2.06 million shs
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$1.47
+0.7%
$1.29
$0.82
$3.25
$37.22M0.59841,655 shs161,553 shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.82
+3.7%
$3.04
$2.37
$8.87
$108.04M0.67165,567 shs174,835 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
+31.87%+25.65%-3.61%-36.93%+479,999,900.00%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-4.40%+16.92%+14.29%+6.67%+65.96%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
+0.68%+8.09%+16.67%-17.88%-9.26%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+3.68%-4.41%+1.44%-41.37%-46.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.2763 of 5 stars
3.65.00.00.03.21.70.6
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.246 of 5 stars
3.74.00.00.03.43.30.0
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.5577 of 5 stars
4.63.00.00.01.60.80.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
3.00
Buy$16.50243.75% Upside
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.20
Buy$3.50130.26% Upside
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.33
Buy$4.75223.13% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
3.20
Buy$14.20403.55% Upside

Current Analyst Ratings Breakdown

Latest MDAI, LUCD, OBIO, and AVR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.00
5/14/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
5/13/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
5/5/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.00
4/23/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/22/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
4/21/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $7.50
4/11/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
4/4/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
4/3/2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/2/2025
Spectral AI, Inc. stock logo
MDAI
Spectral AI
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.50 ➝ $3.50
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
$2.71M63.85N/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$4.17M39.41N/AN/A($0.47) per share-3.23
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$29.96M1.24N/AN/A($0.10) per share-14.70
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$2.89M37.44N/AN/A$1.90 per share1.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-$52.67M-$1.34N/AN/AN/A-1,069.87%N/A-123.54%8/11/2025 (Estimated)
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$20.85M-$0.54N/AN/AN/A-40.78%N/A-77.87%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$49.12M-$1.78N/AN/AN/A-2,179.33%-107.04%-70.88%N/A

Latest MDAI, LUCD, OBIO, and AVR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/A-$0.61N/A-$0.61N/AN/A
5/12/2025Q1 2025
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.46-$0.49-$0.03-$0.49$0.39 million$0.87 million
3/31/2025Q4 2024
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.43-$0.43N/A-$0.43$0.79 million$0.25 million
3/27/2025Q4 2024
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/AN/AN/AN/AN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/A
1.18
1.14
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/A
0.73
0.69
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/A
4.23
4.21

Institutional Ownership

CompanyInstitutional Ownership
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
74.01%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
67.08%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.55%

Insider Ownership

CompanyInsider Ownership
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
6.80%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
56.73%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
13836.06 millionN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
70108.19 million54.12 millionNo Data
Spectral AI, Inc. stock logo
MDAI
Spectral AI
8325.32 million8.04 millionNot Optionable
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
438.31 million35.47 millionNot Optionable

Recent News About These Companies

What is Chardan Capital's Forecast for OBIO FY2026 Earnings?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anteris Technologies Global stock logo

Anteris Technologies Global NASDAQ:AVR

$4.80 +1.16 (+31.87%)
As of 05/27/2025 04:00 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Lucid Diagnostics stock logo

Lucid Diagnostics NASDAQ:LUCD

$1.52 -0.07 (-4.40%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.54 +0.02 (+1.64%)
As of 05/27/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Spectral AI stock logo

Spectral AI NASDAQ:MDAI

$1.47 +0.01 (+0.68%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.47 0.00 (0.00%)
As of 05/27/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$2.82 +0.10 (+3.68%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$2.82 +0.01 (+0.18%)
As of 05/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.